PRINCIPAL FINANCIAL GROUP INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$123,000
-73.3%
103,638
-59.4%
0.00%
Q2 2022$460,000
-25.1%
255,383
-15.9%
0.00%
Q1 2022$614,000
-48.4%
303,691
-30.9%
0.00%
-100.0%
Q4 2021$1,191,000
-61.1%
439,429
-36.0%
0.00%
-50.0%
Q3 2021$3,062,000
-19.4%
686,704
+4.9%
0.00%0.0%
Q2 2021$3,797,000
+71.6%
654,762
+107.7%
0.00%0.0%
Q1 2021$2,213,000
+55.5%
315,309
+6.4%
0.00%
+100.0%
Q4 2020$1,423,000
-46.8%
296,405
-35.3%
0.00%
-50.0%
Q3 2020$2,673,000
+54.5%
458,464
+78.9%
0.00%0.0%
Q2 2020$1,730,000
+467.2%
256,213
+230.6%
0.00%
Q3 2019$305,000
-75.8%
77,511
-8.6%
0.00%
-100.0%
Q2 2019$1,260,000
-40.2%
84,763
-0.2%
0.00%
-50.0%
Q1 2019$2,107,000
+47.8%
84,909
+6.9%
0.00%0.0%
Q4 2018$1,426,000
-45.6%
79,428
-11.0%
0.00%0.0%
Q3 2018$2,621,000
-36.2%
89,226
-1.2%
0.00%
-50.0%
Q2 2018$4,105,000
+20.6%
90,270
+40.1%
0.00%
+33.3%
Q1 2018$3,403,000
-22.4%
64,437
-0.1%
0.00%
-25.0%
Q4 2017$4,385,000
+13.9%
64,478
+38.0%
0.00%0.0%
Q3 2017$3,850,000
-13.2%
46,716
-1.4%
0.00%0.0%
Q2 2017$4,436,000
+922.1%
47,385
+595.2%
0.00%
+300.0%
Q1 2017$434,000
+65.6%
6,816
+15.6%
0.00%
Q4 2016$262,000
+29.7%
5,898
+5.5%
0.00%
Q3 2016$202,000
-96.0%
5,593
-89.7%
0.00%
-100.0%
Q3 2015$4,993,000
+0.6%
54,296
-3.9%
0.01%
+14.3%
Q2 2015$4,963,000
+19.4%
56,475
+0.9%
0.01%
+16.7%
Q1 2015$4,156,000
+33.4%
55,981
+0.6%
0.01%
+20.0%
Q4 2014$3,115,000
+23.3%
55,630
-0.1%
0.01%
+25.0%
Q3 2014$2,526,000
+9.0%
55,695
-0.5%
0.00%0.0%
Q2 2014$2,317,000
-40.1%
55,955
+0.2%
0.00%
-42.9%
Q1 2014$3,867,000
+15.3%
55,821
+0.3%
0.01%
+16.7%
Q4 2013$3,354,000
+14.6%
55,644
+15.6%
0.01%0.0%
Q3 2013$2,926,000
+5.8%
48,144
+16.6%
0.01%0.0%
Q2 2013$2,766,00041,3020.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2017
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders